Aim: To investigate the effects of branched-chain amino acids and vitamin D supplementation on physical function, muscle strength, muscle mass, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation.
Introduction
Sarcopenia, the age-related loss of physical function, muscle strength and muscle mass, largely accounts for physical frailty. Sarcopenia is now considered an independent condition by the 2016 International Classification of Diseases, Tenth Revision, Clinical Modification (M62.84). 1 The preservation or improvement of physical function and independent living are vital in frail older adults, 2 and sarcopenia is a major contributor to physical frailty. 3 Sarcopenia among older adults undergoing in-hospital rehabilitation is an emerging concept. 4, 5 The prevalence of sarcopenia is relatively higher (approximately 50.0%) among older adults undergoing in-hospital rehabilitation than among those in the community or nursing homes. 4, 6 It is widely assumed that the management of sarcopenia is associated with functional and nutritional outcomes in an in-hospital rehabilitation setting. 5 However, only a few randomized controlled trials have reported the effects of interventions for treating sarcopenia in community-dwelling older adults. 7 To our knowledge, only one randomized controlled trial examined the interventional effects of treating sarcopenia with branched-chain amino acids (BCAA) supplementation in an inhospital convalescent rehabilitation setting. 8 Nutritional support is an important therapeutic modality in patients with sarcopenia. The onset and progression of sarcopenia is multidimensional, and involves physical inactivity, altered metabolism, neuromuscular deterioration and poor nutritional status. Factors associated with poor nutritional status in both premorbid and post-acute settings might be modifiable risk factors for sarcopenia. Recent recommendations for preventing and treating sarcopenia include daily and/or supplemental protein and vitamin D intake. [7] [8] [9] Furthermore, given the low sensitivity of old muscles to daily protein intake, BCAA or leucine supplementation should be administered to stimulate muscle protein synthesis. 10, 11 A recent systematic review and meta-analysis provided evidence for the combined effectiveness of exercise and nutritional interventions for treating sarcopenia, and concluded that resistance training should be added to maximize the effects of nutritional interventions. 7 We aimed to analyze whether a combination of resistance training, and a timely bolus of BCAA and vitamin D supplementation would improve physical function, muscle strength, and muscle mass in sarcopenic older adults undergoing in-hospital convalescent rehabilitation.
Methods

Study design and setting
We carried out an 8-week, multicenter, randomized, controlled, open-label, blinded outcome assessment, two-cohort parallel group intervention trial of post-acute older adults with sarcopenia and mobility limitations requiring in-hospital convalescent rehabilitation. The present study was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN000006238), and carried out according to the ethical recommendations of the Declaration of Helsinki and the institutional review board of each hospital that approved the study protocol. All enrolled patients provided written informed consent. Our manuscript complies with the Consolidated Standards of Reporting Trials Statement 2010 (CONSORT 2010 Statement) to improve the quality of reporting (see Appendix S1).
Participants
Participants were recruited from three rehabilitation hospitals, including Heisei Toya Hospital (H Hospital), Kumamoto Rehabilitation Hospital (K Hospital) and Sakurajyuji Hospital (S Hospital), all of which were located in Kumamoto, Japan, between September 2011 and December 2013 (January 2012 and December 2013, February 2012 and December 2013, and September 2011 and March 2012 in H, K and S Hospitals, respectively). Consecutive post-acute admissions on the convalescent rehabilitation wards served as the recruitment pool. Patients were mainly divided into three categories: stroke, musculoskeletal disorders and hospital-associated deconditioning. Older adults (aged ≥65 years) were screened for eligibility. , swallowing difficulties, inability to communicate or understand the purpose of the study and contraindication for a high-protein diet (e.g. chronic renal failure).
Adequate nutritional management was defined as the amount of nutrition that provides sufficient energy intake and was calculated for each patient by an experienced registered dietitian based on nutritional evaluation on the referral day. Energy expenditure was calculated using the Harris-Benedict equation; adjusted for height, weight, age and sex; and multiplied by physical activity and stress factors to determine the total energy requirement. 15 Registered dietitians supervised the daily dietary intake in both groups. All food was provided to the patients by the hospital; no additional food was provided by the patients' families or others.
Within 7 days of admission to a convalescent rehabilitation ward, patients were randomly assigned to an intervention or a control group using a simple randomization method (Microsoft Excel 2010; Microsoft Corporation, Washington DC, WA, USA). Baseline evaluations were carried out by rehabilitation staff ,and registered dietitians and nurses who were not co-investigators.
Rehabilitation program
Patients in both groups underwent an 8-week convalescent rehabilitation program that included physical, occupational and speech-language therapy. Rehabilitation was carried out according to a standard protocol under the guidance of the rehabilitation team. 16 The rehabilitation program (≤3 h/day) was tailored to the functional abilities and disabilities of the patient. For instance, physical therapy included a range of motion exercises, stretching, walking training, activities of daily living (ADL) training and paralyzed limb facilitation (for leg paralysis), and occupational therapy included a range of motion training, stretching, upper limb movement training, ADL training, cognitive training and paralyzed limb facilitation (for upper limb paralysis). In addition, patients in both groups underwent low-intensity resistance training. In a recent meta-analysis, low-intensity resistance training was shown to sufficiently enhance muscle protein synthesis and is therefore recommended for maintaining skeletal muscle mass in frail older adults. 17 In the present study, resistance training consisted of machine and sit-to-stand exercises. Machine exercises included leg press, leg curl and leg extension. For the sitto-stand exercises, patients were allowed to use a handrail or parallel bars, as necessary, and a physical therapist assisted patients who had difficulty in standing up on their own. Patients carried out two sets of 10 repetitions of the sit-to-stand exercise on the first day. For both the machine and sit-to-stand exercises, the number of repetitions was gradually increased as muscle strength and durability improved. The exercises were carried out individually according to each patient's endurance. These exercises were low intensity (20.0-30.0% of 1 repetition maximum) with slow movements, and are therefore useful for increasing muscle strength and muscle mass in older adults. 18 The duration of the convalescent rehabilitation program, including resistance training, was almost identical to the length of hospitalization (from admission to discharge).
Interventions
The intervention group received BCAA and vitamin D supplementation, whereas the control group did not receive them. The supplement, produced by Nestle (Tokyo, Japan), comprised 10.0 g protein (BCAA, 2500 mg) and 12.5 μg vitamin D, and was 200.0 kcal/125.0 mL. The supplement details are shown in Table 1 . Beginning on the first day of the study, the supplement was ingested once a day, within 30 min after the end of the resistance training. Registered dietitians, blinded to the patients' treatment group, supervised daily dietary intake and supplements.
Outcome assessments
Blinded research staff assessed the outcomes at the end of the intervention (hospital discharge). Blinded physical or occupational therapists evaluated the physical condition of the patients at baseline and at the end of the intervention. All patients were evaluated at baseline before allocation to the intervention or control group.
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The primary outcome measure was physical function (ADL performance), determined by the motor domain of the Functional Independence Measure (FIM-motor), one of the most-common tools for assessing ADL performance. 19 The FIM comprises a motor domain (FIM-motor) with 13 items, and a cognitive domain (FIM-cognitive) with five items. Tasks are rated on an ordinal scale ranging from 1 (total assistance) to 7 (complete independence). The FIM, FIM-motor and FIM-cognitive scores are in the range of 18-126, 13-91 and 5-35, respectively. Lower scores indicate poorer ADL performance. Secondary outcome measures included muscle strength (handgrip strength) and muscle mass (CC and arm circumference [AC]). The CC and AC were indicators of skeletal muscle mass and were measured at the largest part of the calf or arm, respectively, without paralysis or contracture, according to a standardized method using a tape measure. A non-paralytic CC ≤31.0 cm (men) or ≤30.0 cm (women) indicated malnutrition with sufficient accuracy and good correlation with functional capacity. 13 CC measurements are simple to carry out and easily applicable in daily practice. Therefore, we assumed that a CC cut-off value ≤31.0 cm (men) or ≤30.0 cm (women) was clinically acceptable. Handgrip strength was measured in the non-dominant hand (or in the case of hemiparesis, the non-paralyzed hand) with the patient in a standing or seated position (depending on their ability) and with their arms straight at their sides using a Smedley's hand dynamometer (TTM, Tokyo, Japan) to standardize the evaluation, because there was a difference in the handgrip strength between the dominant and non-dominant hand. The highest value from two consecutive measurements was recorded. Other secondary outcome measures included nutritional status (BMI), serum albumin levels and the Mini-Nutritional Assessment-Short Form (MNA-SF).
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Product compliance was assessed using actual intake charts, as recorded by nurses and registered dietitians who were not involved in the study. Adequate compliance was defined as consumption of nine of the 10 possible servings every 10 days. Any adverse events were recorded.
Statistical analysis
The study was powered to detect an effect size of 15 for FIM-motor scores. 21, 22 Assuming an alpha error of 0.05 and a two-sided effect, a sample size of 23 per group generated 80.0% statistical power to observe the effect. Baseline characteristics were compared between the intervention and control groups using the Student's t-test, Mann-Whitney U-test and χ 2 -test. Post-intervention characteristics were assessed using an analysis of covariance. Baseline characteristics and hospital variables were included as covariates and means, 95% confidence intervals (CI) and P-values were calculated. The normality assumption was assessed for the analysis of covariance models for handgrip strength, CC, AC, BMI and serum albumin levels. FIM-motor, FIM-cognitive and the MNA-SF were not normally distributed. Group differences in changes from baseline were analyzed using the Mann-Whitney U-test. Median values and corresponding 95% CI were determined using the HodgesLehmann estimator. Both intention-to-treat analyses and perprotocol analyses were carried out. All statistical analyses were carried out using Statistical Package for the Social Sciences for Windows (software version 21; IBM Corporation, Armonk, NY, USA). A P < 0.05 was considered statistically significant.
Results
In total, 247 post-acute patients (71, 66 and 110 patients from H, K and S Hospital, respectively) were screened for their eligibility to participate in the present study, 68 of whom were randomly assigned to the intervention or control group (Fig. 1) . Five participants were removed from the study. Two patients were discharged before the end of the study, and three refused to continue the study. The final intervention and control groups comprised 32 (mean age 78.8 years, 12 men and 20 women) and 31 (mean age 80.9 years, 13 men and 18 women) patients, respectively. The baseline characteristics of the patients are summarized in Table 2 . None of the items examined differed significantly between the two groups at baseline, including age, sex, diagnosis on admission and ADL performance. The mean age of the entire cohort was 79.9 years. The majority of patients were women (60.3%), physically disabled (median FIM-motor score 62) and at risk of malnutrition (median MNA-SF score 8). Intervention compliance was 100.0% from baseline to follow up for all patients in both groups.
All patients received an individually tailored convalescent rehabilitation program and resistance training throughout the study period. The results of intention-to-treat analysis are shown as follows. FIM-motor scores increased significantly in both groups over time (P < 0.05). However, no treatment-by-time effects were observed (median estimated difference 2.4, 95% CI −1.2 to 7.1; Table 3 ). CC and AC increased significantly in both groups over time (P < 0.05). CC, but not AC, showed a significantly greater improvement in the intervention group (P = 0.033). Handgrip strength also increased significantly over time (P < 0.05), with significantly greater improvements in the intervention group (mean estimated difference 0.99, 95% CI 0.44 to 2.50 kg). BMI and serum albumin levels improved significantly over time (P < 0.05), with significant treatment-by-time effects (mean estimated difference, 0.81 kg/m 2 and 0.18 g/dL, respectively). No treatment-bytime effects were observed for FIM-cognitive and the MNA-SF (Table 3) . Per-protocol and intention-to-treat analyses showed statistically similar results. There were no adverse effects reported throughout the intervention period with respect to the nutritional supplement or rehabilitation program, as well as the resistance training.
Discussion
The 8-week administration of BCAA and vitamin D supplementation for post-acute sarcopenic older adults with mobility limitations did not lead to significant improvements in ADL performance. There were, however, significant improvements in muscle strength, muscle mass, BMI and serum albumin levels in the intervention group compared with the control group. These findings suggest that nutritional supplementation, which stimulates muscle protein synthesis in older adults, counteracts muscle loss in such patients.
Resistance training is considered the standard method for increasing physical function, muscle strength and muscle mass. However, in this clinical trial, we aimed to investigate the isolated effect of a specific nutritional intervention. Information on the effects of nutritional supplementation on physical function, muscle strength and muscle mass in sarcopenic older adults is limited and somewhat contradictory. Bauer et al. showed that nutritional supplementation increased muscle mass and chair stand ability, but not handgrip strength or Short Physical Performance Battery scores. 9 Fiatarone et al. reported that nutritional supplementation per se did not affect physical function or muscle mass. 23 A recent systematic review and meta-analysis showed that nutritional intervention with essential amino acids was effective in improving knee extension strength after 3 months of intervention. 7 However, there was no significant effect of nutritional intervention on appendicular skeletal muscle mass (index), fat-free mass, grip strength, walking speed and Timed Up and Go test results. 7 In the present study, we selected post-acute patients with low muscle strength and low muscle mass, showing positive effects of nutritional supplementation on muscle strength and muscle mass. To our knowledge, one study thus far examined the interventional effects of treating sarcopenia in an in-hospital convalescent rehabilitation setting. 8 The present findings are consistent with the Figure 1 Participant screening, randomization and follow up. previously reported results, and strengthen the evidence in the relevant study field.
Approximately 50% of rehabilitation patients are malnourished. 4 Malnutrition is a potential predictor of adverse post-acute outcomes (e.g. physical dependency, muscle weakness, longer hospital stays and lower quality of life). 24 When combined with malnutrition, sarcopenia can further worsen the prognosis of post-acute patients. The present study is useful, because it identifies a viable means of increasing muscle strength, muscle mass and nutritional status in sarcopenic older adults, and focuses on issues that have been largely overlooked by clinicians. Beyond protein quantity, the quality and timing of protein supplementation are critical determinants of physical function, muscle strength and muscle mass. 9 In short-term studies, bolus intake of whey protein and BCAA provided sufficient essential amino acids, particularly leucine, to elicit an appropriate acute muscle protein synthesis response. 25, 26 Leucine is an important trigger of postprandial muscle protein synthesis, and acts through the mammalian target of rapamycin signaling pathway. 27 The consumption of essential amino acids enriched in BCAA, such as leucine, as described in the present trial, increases muscle protein synthesis and alleviates muscle soreness after exercise. 28 Therefore, BCAA and leucine supplementation appear to preserve muscle mass and physical function in sarcopenic older adults with reduced food intake. Additionally, reversing vitamin D deficiency in combination with BCAA and essential amino acids supplementation might have contributed to the favorable effect on muscle parameters. 29 These findings show that BCAA and vitamin D supplementation might be associated with better muscle-related outcomes in sarcopenic older adults and therefore support the present results, although the present study did not address the separate effects of BCAA, vitamin D and other nutrients.
To maximize the effects of nutritional intervention, the present patients also received low-intensity resistance training as part of their rehabilitation program. Because the patients were older adults with physical limitations, we selected machine and sit-to-stand exercises from the many resistance training exercises available, because they are easy to carry out and assistance can be provided, if necessary. Low-intensity resistance training with slow movements has been shown to be a safe and effective way to increase muscle strength and muscle mass in frail older adults. 18 The present study had several limitations. First, although the relatively small sample size and sample heterogeneity, including sex (there were more women in the intervention group, but without a significant difference), did not affect the outcome, these factors might limit the generalization of the results. Second, a control group that did not carry out resistance training was lacking. Thus, the present study did not address the separate effects of nutrition and exercise. Third, physical activity level, the numbers and sets of resistance training, and dietary intake were not recorded. This might have affected the results over time. Fourth, we adapted CC and AC as muscle-mass indicators, but these parameters might not be accurate for the quantification of muscle mass. Finally, we did not examine the serum vitamin D levels. Therefore, we did not remove patients with vitamin D deficiency, which limits the effectiveness of vitamin D supplementation.
In conclusion, an 8-week intervention consisting of BCAA and vitamin D supplementation with low-intensity resistance training increases muscle strength, muscle mass and nutritional status in post-acute sarcopenic older adults. The present study highlights the efficacy and safety of this approach, which is especially suitable for older adults with physical limitations. However, further studies are required to determine how nutritional supplementation improves the outcomes of sarcopenic older adults in combination with other rehabilitation procedures.
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